Pfizer Defends Its Minority Fellowship Program For Minorities
In the wake of a discrimination lawsuit, Pfizer is defending its minority fellowship program, saying it serves the public interest.
Stay updated with breaking news from Breakthrough Fellowship Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the wake of a discrimination lawsuit, Pfizer is defending its minority fellowship program, saying it serves the public interest.
What's next? Not exclusively giving jobs to people with millionaire parents?
By Jonathan Stempel NEW YORK (Reuters) - Pfizer Inc said its fellowship program for minorities serves the public interest, as the drugmaker defends against a lawsuit by a group of medical professionals that claims the
Pfizer Inc said its fellowship program for minorities serves the public interest, as the drugmaker defends against a lawsuit by a group of medical professionals that claims the program illegally excludes whites and Asian-Americans. In a Tuesday night filing, Pfizer urged a Manhattan federal judge to reject Do No Harm's request for an injunction against filling the 2023 class for its Breakthrough Fellowship Program, which enrolls Blacks, Latinos and Native Americans. Pfizer said the two-year-old program helps address historical discrimination in the workplace, and difficulties in recruit...
A weekly roundup of healthcare's encounters with the courts